Patent ID: 11970743
Assignee: DENDREON PHARMACEUTICALS LLC
Field: Biotechnology (Chemistry)
Classification: CPC C | IPC C

Claim 11:
12. The method of claim 11, further comprising correlating the first composite score of the expression product levels of the biomarkers measured in step (b) to reference expression values from mCRPC patients grouped into overall survival groups, wherein the step of correlating the first composite score further comprises correlating (i) the first composite score of the biomarker expression product levels of SNTB1, SYNGR3, AURKC, ZNF268, and CHI3L2 of the patient and (ii) the PSA level, LDH level, Alkaline phosphatase level, Hemoglobin level, Total Gleason Score, ECOG status to reference values of (i) and (ii) from mCRPC patients grouped into overall survival groups.